23andMe Wants to Make Drugs—Here's What That Could Mean in 10 Years

23andMe made a name for itself selling DNA test kits, but today it announced a radical new direction: The company will start mining its huge database of DNA sequences to create new drugs. The science of how they could do that is fascinating—but it raises a lot of futuristic ethical questions too. » 3/12/15 8:25pm 3/12/15 8:25pm

Of Course 23andMe's Plan Has Been to Sell Your Genetic Data All Along

Today, 23andMe announced what Forbes reports is only the first of ten deals with big biotech companies: Genentech will pay up to $60 million for access to 23andMe's data to study Parkinson's. You think 23andMe was about selling fun DNA spit tests for $99 a pop? Nope, it's been about selling your data all along. » 1/06/15 3:35pm 1/06/15 3:35pm

Why Genetic Testing Is So Important For Sports

Fast Company has a profile on 23andMe, the de facto public face of genetic testing, that's worth a read just for the look at the underpinnings of the science. But there's a moment in there that teases out the gut punch that can come from that knowledge, and that's closely related to how genetic testing in sports might… » 10/16/13 5:12pm 10/16/13 5:12pm

It Now Only Costs $100 To Know Everything About Your DNA

Mapping out your genome is the 21st Century equivalent of staring deep inside your soul; it's tempting to look, but terrifying what you might find. The DNA divers at 23andMe are hoping that slashing the price of their home-testing service—from $300 down to $100—will be enough to tilt the scales towards discovery. Are… » 12/13/12 8:58am 12/13/12 8:58am